A. C. Hunter

发表

Cationic carriers of genetic material and cell death: a mitochondrial tale.

S. Moghimi, A. C. Hunter, S. Moghimi, 2010, Biochimica et biophysica acta.

Polycation cytotoxicity: a delicate matter for nucleic acid therapy-focus on polyethylenimine

T. Andresen, S. Moghimi, L. Parhamifar, 2010 .

Molecular hurdles in polyfectin design and mechanistic background to polycation induced cytotoxicity.

A. C. Hunter, 2006, Advanced drug delivery reviews.

A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy.

S Moein Moghimi, A Christy Hunter, A. Szewczyk, 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

Polyethylenimine-mediated impairment of mitochondrial membrane potential, respiration and membrane integrity: implications for nucleic acid delivery and gene therapy.

S. Moghimi, L. Parhamifar, A. C. Hunter, 2012, Mitochondrion.

Cellular Distribution of Nonionic Micelles

S. Moghimi, A. C. Hunter, J. C. Murray, 2004, Science.

Nanomedicine: current status and future prospects

A. C. Hunter, S. M. Moghimi, J. C. Murray, 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Distinct polymer architecture mediates switching of complement activation pathways at the nanosphere-serum interface: implications for stealth nanoparticle engineering.

S Moein Moghimi, A Christy Hunter, Thomas L Andresen, 2010, ACS nano.

Material properties in complement activation.

Davoud Ahmadvand, S Moein Moghimi, A Christy Hunter, 2011, Advanced drug delivery reviews.

Long-circulating and target-specific nanoparticles: theory to practice.

S M Moghimi, A C Hunter, S. Moghimi, 2001, Pharmacological reviews.

Complement: alive and kicking nanomedicines.

S Moein Moghimi, A Christy Hunter, Thomas L Andresen, 2009, Journal of biomedical nanotechnology.

The Interplay Between Blood Proteins, Complement, and Macrophages on Nanomedicine Performance and Responses

D. Simberg, S. Moghimi, A. C. Hunter, 2019, The Journal of Pharmacology and Experimental Therapeutics.

PEGylation of microspheres generates a heterogeneous population of particles with differential surface characteristics and biological performance

S. Moghimi, A. C. Hunter, S. M. Moghimi, 2002, FEBS letters.

Therapeutic synthetic polymers: a game of Russian roulette?

S. Moghimi, A. C. Hunter, 2002, Drug discovery today.

Real‐time evidence of surface modification at polystyrene lattices by poloxamine 908 in the presence of serum: in vivo conversion of macrophage‐prone nanoparticles to stealth entities by poloxamine 908

S. Moghimi, A. C. Hunter, K. Pavey, 2003, FEBS letters.

Surfactant-mediated complement activation in beagle dogs.

S. Moghimi, J. Szebeni, A. C. Hunter, 2013, International immunopharmacology.

Complement activation by PEG-functionalized multi-walled carbon nanotubes is independent of PEG molecular mass and surface density.

T. Andresen, S. Moghimi, A. C. Hunter, 2013, Nanomedicine : nanotechnology, biology, and medicine.

Causative factors behind poloxamer 188 (Pluronic F68, Flocor)-induced complement activation in human sera. A protective role against poloxamer-mediated complement activation by elevated serum lipoprotein levels.

S. Moghimi, C. Alving, J. Szebeni, 2004, Biochimica et biophysica acta.

Bypassing particle-mediated adverse injection reactions through shape modification and erythrocyte ‘ hitch-hiking ’

P. Nilsson, S. Mitragotri, S. Moghimi, 2018 .

A brief history of long circulating nanoparticles.

Z. S. Farhangrazi, S. Moghimi, A. C. Hunter, 2022, Advanced drug delivery reviews.

Particulate nanomedicine in the footsteps of platelet homing.

S. Moghimi, A. C. Hunter, I. Hamad, 2007, Nanomedicine.

Modification of the Stewart biphasic colorimetric assay for stable and accurate quantitative determination of Pluronic and Tetronic block copolymers for application in biological systems.

S. Moghimi, A. C. Hunter, O. Al-Hanbali, 2007, Analytical biochemistry.

Synthetic polymers in 21st century therapeutics: the way forward.

S. Moghimi, A. C. Hunter, 2003, Drug discovery today.

Real-time evaluation of macromolecular surface modified quartz crystal resonant sensors under cryogenic stress for biological applications.

A. C. Hunter, K. Pavey, F. Paul, 2003, Biosensors & bioelectronics.

Blood hot in Boston.

A. C. Hunter, 2002, Drug discovery today.

Variation of complement activation in human serum by Poloxamer 188 (Pluronic-F68)

S. Moghimi, C. Alving, J. Szebeni, 2001 .

Pharmacological Potential of Lathyrane-Type Diterpenoids from Phytochemical Sources

A. C. Hunter, R. Hernández-Galán, A. J. Macías-Sánchez, 2022, Pharmaceuticals.

Complement monitoring of carbon nanotubes.

S. Moghimi, A. C. Hunter, 2010, Nature nanotechnology.

Fate of novel Quasi reverse steroidal substrates by Aspergillus tamarii KITA: bypass of lactonisation and an exclusive role for the minor hydroxylation pathway.

A. C. Hunter, J. Elsom, Seamus Kennedy, 2005, Biochimica et biophysica acta.

Complement monitoring of nanomedicines and implants.

S. Moghimi, A. C. Hunter, 2011, Advanced drug delivery reviews.

Transformation of 5-ene steroids by the fungus Aspergillus tamarii KITA: mixed molecular fate in lactonization and hydroxylation pathways with identification of a putative 3beta-hydroxy-steroid dehydrogenase/Delta5-Delta4 isomerase pathway.

A. C. Hunter, C. Dedi, E. Coyle, 2009, Biochimica et biophysica acta.

Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective.

S M Moghimi, A C Hunter, T L Andresen, 2012, Annual review of pharmacology and toxicology.

Recognition by Macrophages and Liver Cells of Opsonized Phospholipid Vesicles and Phospholipid Headgroups

S. Moein Moghimi, A. Christy Hunter, S. Moghimi, 2004, Pharmaceutical Research.

Distinct metabolic handling of 3beta-hydroxy-17a-oxa-D-homo-5alpha-androstan-17-one by the filamentous fungus Aspergillus tamarii KITA: Evidence in support of steroid/hydroxylase binding hypothesis.

A. C. Hunter, Hild Bergin-Simpson, 2007, Biochimica et biophysica acta.

Ring-B functionalized androst-4-en-3-ones and ring-C substituted pregn-4-en-3-ones undergo differential transformation in Aspergillus tamarii KITA: ring-A transformation with all C-6 substituted steroids and ring-D transformation with C-11 substituents.

A. C. Hunter, J. Elsom, Linda Ross, 2006, Biochimica et biophysica acta.

Transformation of structurally diverse steroidal analogues by the fungus Corynespora cassiicola CBS 161.60 results in generation of 8β-monohydroxylated metabolites with evidence in favour of 8β-hydroxylation through inverted binding in the 9α-hydroxylase.

S. Moghimi, A. C. Hunter, C. Dedi, 2011, Biochimica et biophysica acta.

Quartz Crystal Microbalance Assay of Clinical Calcinosis Samples and Their Synthetic Models Differentiates the Efficacy of Chelation-Based Treatments.

A. Herrick, N. Lockyer, A. C. Hunter, 2017, ACS applied materials & interfaces.

Poloxamers and poloxamines in nanoparticle engineering and experimental medicine.

S M Moghimi, A C Hunter, S. Moghimi, 2000, Trends in biotechnology.

The gastroduodenal mucus barrier and the place of eicosanoids

A. C. Hunter, J. Keogh, A. Allen, 1988 .

Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective.

S. Moghimi, A. C. Hunter, P. P. Wibroe, 2012, Maturitas.

Platelet mimicry: The emperor's new clothes?

Dan Peer, D. Peer, S. Moghimi, 2016, Nanomedicine : nanotechnology, biology, and medicine.

Complement activation cascade triggered by PEG-PL engineered nanomedicines and carbon nanotubes: the challenges ahead.

J Szebeni, S M Moghimi, A C Hunter, 2010, Journal of controlled release : official journal of the Controlled Release Society.

Perspectives on complement and phagocytic cell responses to nanoparticles: From fundamentals to adverse reactions☆

D. Simberg, S. Moghimi, E. Papini, 2023, Journal of controlled release : official journal of the Controlled Release Society.

Bypassing adverse injection reactions to nanoparticles through shape modification and attachment to erythrocytes.

Samir Mitragotri, Seyed Moein Moghimi, Vivek Gupta, 2017, Nature nanotechnology.

Particulate Systems for Targeting of Macrophages: Basic and Therapeutic Concepts

T. Andresen, D. Ahmadvand, S. Moghimi, 2012, Journal of Innate Immunity.

Poly(ethylene glycol)s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent process.

S. Moghimi, J. Szebeni, A. C. Hunter, 2008, Molecular immunology.

Smart polymers in drug delivery: a biological perspective

S. Moein Moghimi, A. Christy Hunter, S. Moghimi, 2017 .

Volume-Activated Chloride Currents in HeLa Cells are Blocked by Tamoxifen But Not by a Membrane Impermeant Quaternary Analogue

A. C. Hunter, S. Hardy, M. Allen, 2001, Cellular Physiology and Biochemistry.

Membrane impermeant antioestrogens discriminate between ligand- and voltage-gated cation channels in NG108-15 cells.

A. C. Hunter, S. Hardy, M. Allen, 2000, Biochimica et biophysica acta.

Complement monitoring of Pluronic 127 gel and micelles: suppression of copolymer-mediated complement activation by elevated serum levels of HDL, LDL, and apolipoproteins AI and B-100.

S. Moghimi, A. C. Hunter, I. Hamad, 2013, Journal of controlled release : official journal of the Controlled Release Society.

Complement system and the brain: selected pathologies and avenues toward engineering of neurological nanomedicines.

S. Moghimi, A. C. Hunter, A. J. Andersen, 2012, Journal of controlled release : official journal of the Controlled Release Society.

AFM visualization of sub-50nm polyplex disposition to the nuclear pore complex without compromising the integrity of the nuclear envelope.

S. Moghimi, L. Parhamifar, H. Andersen, 2016, Journal of controlled release : official journal of the Controlled Release Society.

Low and high molecular weight poly(l‐lysine)s/poly(l‐lysine)–DNA complexes initiate mitochondrial‐mediated apoptosis differently

S Moein Moghimi, A Christy Hunter, A. Szewczyk, 2005, FEBS letters.

Novel quartz crystal microbalance based biosensor for detection of oral epithelial cell-microparticle interaction in real-time.

A Christy Hunter, A. C. Hunter, Gareth D Rees, 2008, Biosensors & bioelectronics.

Application of the quartz crystal microbalance to nanomedicine.

A. C. Hunter, 2009, Journal of biomedical nanotechnology.

Single-walled carbon nanotube surface control of complement recognition and activation.

Hongjie Dai, S Moein Moghimi, A Christy Hunter, 2013, ACS nano.

Studies on mucus biosynthesis in the gastrointestinal tract.

A. C. Hunter, A. Allen, A. Garner, 1989, Symposia of the Society for Experimental Biology.

Genomic perspectives in inter-individual adverse responses following nanomedicine administration: The way forward.

S. Moghimi, A. C. Hunter, P. P. Wibroe, 2012, Advanced drug delivery reviews.

Capture of stealth nanoparticles by the body's defences.

S. Moghimi, A. C. Hunter, C. Hunter, 2001, Critical reviews in therapeutic drug carrier systems.

Concentration dependent structural ordering of poloxamine 908 on polystyrene nanoparticles and their modulatory role on complement consumption.

Dipak K. Sarker, S M Moghimi, A C Hunter, 2006, Journal of nanoscience and nanotechnology.

Ordering of binary polymeric nanoparticles on hydrophobic surfaces assembled from low volume fraction dispersions.

F. Besenbacher, P. Kingshott, R. Mukhopadhyay, 2007, Journal of the American Chemical Society.

Airborne Particulate Matter and SARS-CoV-2 Partnership: Virus Hitchhiking, Stabilization and Immune Cell Targeting — A Hypothesis

G. Sancini, S. Moghimi, A. C. Hunter, 2020, Frontiers in Immunology.

Bypassing adverse injection reactions to nanoparticles through shape 1 modification and erythrocyte ‘hitch-hiking’

P. Nilsson, S. Mitragotri, S. Moghimi, 2017 .

Relative Sensitivity to Acid Injury of Different Regions of the Intestinal Tract

A. C. Hunter, S. Bastaki, A. Allen, 1994 .